Tinea Capitis Survey in Charleston, S.C.

Terreni, Anne A.

doi:10.1001/archderm.1961.01580070094009

Cited by 20 publications

(5 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This organism may have been introduced into the Southwest from Mexico and Puerto Rico ( 12, 13). Other areas in the United States also confirmed an increase in T. tonsurans tinea capitis ( 14–18). While the incidence of T. tonsurans continued to rise in the United States, the frequency with which M. audouinii could be recovered from patients with tinea capitis was decreasing ( 14–18).…”

Section: Epidemiologymentioning

confidence: 78%

Tinea Capitis: An Overview with Emphasis on Management

Gupta

Hofstader

Adam

et al. 1999

Pediatric Dermatology

View full text Add to dashboard Cite

Tinea capitis is perhaps the most common mycotic infection in children. In North America the epidemiology of tinea capitis has changed so that Trichophyton tonsurans now predominates over Micro-sporum audouinii. With this transition the utility of the Wood's light for diagnosis has been reduced since T. tonsurans infection is Wood's light negative. Griseofulvin has been the mainstay of therapy for the last 40 years. The newer antifungal agents-itraconazole, terbinafine, and fluconazole-appear to be effective and safe for the treatment of tinea capitis. When tinea capitis is due to T. tonsurans or other endothrix species the following regimens have been used: itraconazole continuous regimen (5 mg/kg/day for 4 weeks), itraconazole pulse regimen with capsules (5 mg/kg/day for 1 week plus 1-3 pulses 3 weeks apart), and itraconazole pulse regimen with oral solution (3 mg/kg/day for 1 week plus 1-3 pulses 3 weeks apart). With terbinafine tablets the continuous regimen (>40 kg body weight, 250 mg/day; 20-40 kg, 125 mg/day; and <20 kg, 125 mg/day) is given for 2 to 4 weeks. Fluconazole tablets or oral suspension (6 mg/kg/day) were administered for 20 days in one trial. Another possibility may be 6 mg/kg/day for 2 weeks and evaluating the scalp 4 weeks later. An extra week of therapy (6 mg/kg/day) can be administered if clinically indicated at that time. A once-weekly regimen may also be effective. When ectothrix organisms (e.g., Microsporum canis) are present, a longer duration of therapy may be required. The data suggest that the newer agents are effective, safe with few adverse effects, and have a high benefit:risk ratio. It remains to be seen to what extent griseofulvin will be superseded for the treatment of tinea capitis. Adjunctive therapies may help decrease the risk of infection to other individuals. Appropriate measures should be taken to reduce the possibility of reinfection.

show abstract

Section: Epidemiologymentioning

confidence: 78%

Tinea Capitis: An Overview with Emphasis on Management

Gupta

Hofstader

Adam

et al. 1999

Pediatric Dermatology

View full text Add to dashboard Cite

show abstract

“…11 Reports from the United States cited M. audouinii and T. tonsurans as common isolates. [12][13][14][15] In Western Australia, M. canis occurred most commonly. 16 Table 1 summarizes and compares these different regional findings.…”

Section: 10mentioning

confidence: 99%

Scalp Fungus Infections in the Eastern ProvinceOf Saudi Arabia

1989

View full text Add to dashboard Cite

“…[4][5][6] Small-scale investigations targeting "high-risk" (ie, minority) or selfreferred populations have attempted to define T tonsurans infection rates; however, little is known about the prevalence of this pathogen in the general pediatric population. [7][8][9][10][11][12] Moreover, only a single investigation conducted among preschool-aged children examined at the molecular level the fungal isolates recovered from infected children, to ascertain the nature of transmission within the population. 13 The striking infection prevalence and endemic nature of disease observed in young children prompted the consideration of infection patterns as children transition from preschool to primary school.…”

mentioning

confidence: 99%